Literature DB >> 15720799

Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.

Roderick H J Breuer1, Peter J F Snijders, Egbert F Smit, Thomas G Sutedja, Richard G A B Sewalt, Arie P Otte, Folkert J van Kemenade, Pieter E Postmus, Chris J L M Meijer, Frank M Raaphorst.   

Abstract

Polycomb group (PcG) genes are responsible for maintenance of cellular identity and contribute to regulation of the cell cycle. Recent studies have identified several PcG genes as oncogenes, and a role for PcG proteins in human oncogenesis is suspected. We investigated the expression of BMI-1 and EZH2 PcG oncogenes in human bronchial squamous cell carcinomas (SCCs) and bronchial premalignant precursor lesions (PLs). Whereas normal bronchial epithelium was associated with widespread expression of BMI-1 in resting EZH2-negative cells, neoplastic cells in lung carcinomas displayed altered expression of both BMI-1 and EZH2. Two patterns of abnormal PcG expression were observed: increased expression of BMI-1 in dividing neoplastic cells of PLs and SCCs, and enhanced expression of EZH2 and Ki-67 in BMI-1-positive cells according to severity of the histopathologic stage. We propose that altered expression of BMI-1 and EZH2 is an early event that precedes high rates of proliferation in lung cancer. Because PcG complexes are normally involved in the maintenance of cell characteristics, abnormal PcG expression may contribute to loss of cell identity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15720799      PMCID: PMC1531677          DOI: 10.1593/neo.04160

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  51 in total

Review 1.  Cell memory and cancer--the story of the trithorax and Polycomb group genes.

Authors:  C Caldas; S Aparicio
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

Review 2.  Molecular and genetic aspects of lung cancer.

Authors:  W N Rom; J G Hay; T C Lee; Y Jiang; K M Tchou-Wong
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

Review 3.  Polycomb silencing and the maintenance of stable chromatin states.

Authors:  V Pirrotta
Journal:  Results Probl Cell Differ       Date:  1999

4.  HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties.

Authors:  J I Bárdos; A J Saurin; C Tissot; E Duprez; P S Freemont
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

5.  Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation.

Authors:  J van der Vlag; A P Otte
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

6.  Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.

Authors:  F M Raaphorst; F J van Kemenade; T Blokzijl; E Fieret; K M Hamer; D P Satijn; A P Otte; C J Meijer
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

7.  A Drosophila ESC-E(Z) protein complex is distinct from other polycomb group complexes and contains covalently modified ESC.

Authors:  J Ng; C M Hart; K Morgan; J A Simon
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers.

Authors:  F M Raaphorst; F J van Kemenade; E Fieret; K M Hamer; D P Satijn; A P Otte; C J Meijer
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

9.  The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus.

Authors:  J J Jacobs; K Kieboom; S Marino; R A DePinho; M van Lohuizen
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

10.  The Drosophila Polycomb Group proteins ESC and E(Z) are present in a complex containing the histone-binding protein p55 and the histone deacetylase RPD3.

Authors:  F Tie; T Furuyama; J Prasad-Sinha; E Jane; P J Harte
Journal:  Development       Date:  2001-01       Impact factor: 6.868

View more
  44 in total

Review 1.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

Review 2.  Gene silencing and Polycomb group proteins: an overview of their structure, mechanisms and phylogenetics.

Authors:  Shahram Golbabapour; Nazia Abdul Majid; Pouya Hassandarvish; Maryam Hajrezaie; Mahmood Ameen Abdulla; A Hamid A Hadi
Journal:  OMICS       Date:  2013-06

3.  Repression of E-cadherin by the polycomb group protein EZH2 in cancer.

Authors:  Q Cao; J Yu; S M Dhanasekaran; J H Kim; R-S Mani; S A Tomlins; R Mehra; B Laxman; X Cao; J Yu; C G Kleer; S Varambally; A M Chinnaiyan
Journal:  Oncogene       Date:  2008-09-22       Impact factor: 9.867

4.  The Bmi-1 helix-turn and ring finger domains are required for Bmi-1 antagonism of (-) epigallocatechin-3-gallate suppression of skin cancer cell survival.

Authors:  Sivaprakasam Balasubramanian; Tiffany M Scharadin; Bingshe Han; Wen Xu; Richard L Eckert
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

5.  A proteasome inhibitor-stimulated Nrf1 protein-dependent compensatory increase in proteasome subunit gene expression reduces polycomb group protein level.

Authors:  Sivaprakasam Balasubramanian; Santosh Kanade; Bingshe Han; Richard L Eckert
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

6.  Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.

Authors:  Sharon Hensley Alford; Katherine Toy; Sofia D Merajver; Celina G Kleer
Journal:  Breast Cancer Res Treat       Date:  2011-05-26       Impact factor: 4.872

7.  Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.

Authors:  Fang Yang; Li-Zhi Lv; Qiu-Cheng Cai; Yi Jiang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

8.  EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.

Authors:  Carmen Behrens; Luisa M Solis; Heather Lin; Ping Yuan; Ximing Tang; Humam Kadara; Erick Riquelme; Hector Galindo; Cesar A Moran; Neda Kalhor; Stephen G Swisher; George R Simon; David J Stewart; J Jack Lee; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

9.  The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.

Authors:  Sivaprakasam Balasubramanian; Gautam Adhikary; Richard L Eckert
Journal:  Carcinogenesis       Date:  2009-12-16       Impact factor: 4.944

10.  Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.

Authors:  Manjari Dimri; Prashant V Bommi; Anagh A Sahasrabuddhe; Janardan D Khandekar; Goberdhan P Dimri
Journal:  Carcinogenesis       Date:  2009-12-07       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.